Thermosoftening of Double-lumen Tube for Airway Exchanger Catheter
Effect of Thermal-softening of Double-lumen Endobronchial Tubes on Success Rate of Airway Exchange Catheter
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Jae-Hyon Bahk, MD, PhD
- Phone Number: 82-2-2072-2818
- Email: bahkjh@snu.ac.kr
Study Contact Backup
- Name: Susie Yoon, MD
- Phone Number: 82-2-2072-7361
- Email: susiey87@gmail.com
Study Locations
-
-
-
Seoul, Korea, Republic of, 110-744
- Seoul National University Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients undergoing thoracic surgery that requires bronchoscopy study before the placement of double-lumen tubes
Exclusion Criteria:
- Preoperative hoarseness or a sore throat
- History of upper airway diseases
- Anticipated difficult airway
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: non-thermosoftening
Double-lumen tube is put into a bottle of normal saline at room temperature (25°C) before intubation.
|
By using airway exchange catheter, tube exchange is performed from single to double lumen tube that was put into normal saline at room temperature.
|
|
Experimental: thermosoftening
Double-lumen tube is put into a bottle of warm normal saline (40°C) before intubation.
|
By using airway exchange catheter, tube exchange is performed from single to double lumen tube that was put into warm normal saline (40°C).
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time to intubate
Time Frame: Intraoperative (During exchanging single- to double-lumen tube)
|
Length of time to exchange endotracheal tube from single- to double-lumen tube using airway exchange catheter.
|
Intraoperative (During exchanging single- to double-lumen tube)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative hoarseness (4-points scoring)
Time Frame: up to 48 hours after surgery
|
up to 48 hours after surgery
|
|
|
postoperative sore throat (4-points scoring)
Time Frame: up to 48 hours after surgery
|
up to 48 hours after surgery
|
|
|
Vocal cord injuries assessed by videolaryngoscope
Time Frame: up to 1 hour after double-lumen tube extubation
|
vocal cord injuries observed after tube-exchange
|
up to 1 hour after double-lumen tube extubation
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: Jae-Hyon Bahk, MD, PhD, Seoul National University Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Neurologic Manifestations
- Stomatognathic Diseases
- Nervous System Diseases
- Respiratory Tract Infections
- Infections
- Respiratory Tract Diseases
- Respiration Disorders
- Otorhinolaryngologic Diseases
- Signs and Symptoms, Respiratory
- Pharyngeal Diseases
- Laryngeal Diseases
- Voice Disorders
- Hoarseness
- Pharyngitis
Other Study ID Numbers
Other Study ID Numbers
- JHBahk_DLT_AEC
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.